AtriCure. has been granted a patent for a medical ablation device designed for minimally invasive and open surgical procedures. The device features a helical electrode, flexible shaft sections, and pacing electrodes, allowing targeted therapeutic treatment of tissue with controlled deflection capabilities. GlobalData’s report on AtriCure gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on AtriCure, Surgical robots was a key innovation area identified from patents. AtriCure's grant share as of July 2024 was 55%. Grant share is based on the ratio of number of grants to total number of patents.
Medical ablation device for tissue treatment in surgery
The patent US12059200B2 describes a medical ablation device designed for precise tissue ablation procedures. Central to the device is an ablation assembly featuring a helical electrode housed within a structure that includes an opening. The device comprises a shaft with distinct sections: a flexible distal section, a less flexible proximal section, and a handle equipped with an actuator. This actuator controls a steering member that facilitates the deflection of the distal section in a specific plane, while the proximal end of the shaft is designed to bend in a perpendicular plane. The device also incorporates multiple pacing electrodes positioned between the helical electrode turns, ensuring they are in contact with the tissue during operation.
Additional features of the ablation device include a locking mechanism on the handle to maintain the distal section's shape, a shaft with multiple lumens for flushing and guidewire access, and a slotted tube design that enhances flexibility. The housing of the device is also deflectable, allowing for improved maneuverability. Furthermore, the device is equipped with navigation elements that provide virtual images in an electroanatomic mapping system, aiding in the visualization of the device's position and orientation during procedures. These innovations aim to enhance the efficacy and safety of medical ablation treatments.
To know more about GlobalData’s detailed insights on AtriCure, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
